Toll Free: 1-888-928-9744
Published: Aug, 2018 | Pages:
98 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)
This report focuses on the global Overactive Bladder Treatment Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Overactive Bladder Treatment Drug development in United States, Europe and China. In 2017, the global Overactive Bladder Treatment Drug market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The key players covered in this study Astellas Pharma, Inc. (Japan) Pfizer, Inc. (U.S.) Teva Pharmaceutical Industries Limited (Israel) Allergan, Plc (Ireland) Medtronic plc (Ireland) Mylan N.V. (U.S.) Endo International plc (Ireland) Hisamitsu Pharmaceutical Co., Inc. (Japan) Sanofi (France) Apotex, Inc. (Canada) Cogentix Medical, Inc. (U.S.) Aurobindo Pharma Limited (India) Market segment by Type, the product can be split into Anticholinergics Solifenacin Oxybutynin Darifenacin Fesoterodine Tolterodine Trospium Others Market segment by Application, split into Idiopathic Bladder Overactivity Neurogenic Bladder Overactivity Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Overactive Bladder Treatment Drug status, future forecast, growth opportunity, key market and key players. To present the Overactive Bladder Treatment Drug development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Overactive Bladder Treatment Drug are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Overactive Bladder Treatment Drug Market Size Growth Rate by Type (2013-2025) 1.4.2 Anticholinergics 1.4.3 Solifenacin 1.4.4 Oxybutynin 1.4.5 Darifenacin 1.4.6 Fesoterodine 1.4.7 Tolterodine 1.4.8 Trospium 1.4.9 Others 1.5 Market by Application 1.5.1 Global Overactive Bladder Treatment Drug Market Share by Application (2013-2025) 1.5.2 Idiopathic Bladder Overactivity 1.5.3 Neurogenic Bladder Overactivity 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Overactive Bladder Treatment Drug Market Size 2.2 Overactive Bladder Treatment Drug Growth Trends by Regions 2.2.1 Overactive Bladder Treatment Drug Market Size by Regions (2013-2025) 2.2.2 Overactive Bladder Treatment Drug Market Share by Regions (2013-2018) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Overactive Bladder Treatment Drug Market Size by Manufacturers 3.1.1 Global Overactive Bladder Treatment Drug Revenue by Manufacturers (2013-2018) 3.1.2 Global Overactive Bladder Treatment Drug Revenue Market Share by Manufacturers (2013-2018) 3.1.3 Global Overactive Bladder Treatment Drug Market Concentration Ratio (CR5 and HHI) 3.2 Overactive Bladder Treatment Drug Key Players Head office and Area Served 3.3 Key Players Overactive Bladder Treatment Drug Product/Solution/Service 3.4 Date of Enter into Overactive Bladder Treatment Drug Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Overactive Bladder Treatment Drug Market Size by Type (2013-2018) 4.2 Global Overactive Bladder Treatment Drug Market Size by Application (2013-2018) 5 United States 5.1 United States Overactive Bladder Treatment Drug Market Size (2013-2018) 5.2 Overactive Bladder Treatment Drug Key Players in United States 5.3 United States Overactive Bladder Treatment Drug Market Size by Type 5.4 United States Overactive Bladder Treatment Drug Market Size by Application 6 Europe 6.1 Europe Overactive Bladder Treatment Drug Market Size (2013-2018) 6.2 Overactive Bladder Treatment Drug Key Players in Europe 6.3 Europe Overactive Bladder Treatment Drug Market Size by Type 6.4 Europe Overactive Bladder Treatment Drug Market Size by Application 7 China 7.1 China Overactive Bladder Treatment Drug Market Size (2013-2018) 7.2 Overactive Bladder Treatment Drug Key Players in China 7.3 China Overactive Bladder Treatment Drug Market Size by Type 7.4 China Overactive Bladder Treatment Drug Market Size by Application 8 Japan 8.1 Japan Overactive Bladder Treatment Drug Market Size (2013-2018) 8.2 Overactive Bladder Treatment Drug Key Players in Japan 8.3 Japan Overactive Bladder Treatment Drug Market Size by Type 8.4 Japan Overactive Bladder Treatment Drug Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Overactive Bladder Treatment Drug Market Size (2013-2018) 9.2 Overactive Bladder Treatment Drug Key Players in Southeast Asia 9.3 Southeast Asia Overactive Bladder Treatment Drug Market Size by Type 9.4 Southeast Asia Overactive Bladder Treatment Drug Market Size by Application 10 India 10.1 India Overactive Bladder Treatment Drug Market Size (2013-2018) 10.2 Overactive Bladder Treatment Drug Key Players in India 10.3 India Overactive Bladder Treatment Drug Market Size by Type 10.4 India Overactive Bladder Treatment Drug Market Size by Application 11 Central & South America 11.1 Central & South America Overactive Bladder Treatment Drug Market Size (2013-2018) 11.2 Overactive Bladder Treatment Drug Key Players in Central & South America 11.3 Central & South America Overactive Bladder Treatment Drug Market Size by Type 11.4 Central & South America Overactive Bladder Treatment Drug Market Size by Application 12 International Players Profiles 12.1 Astellas Pharma, Inc. (Japan) 12.1.1 Astellas Pharma, Inc. (Japan) Company Details 12.1.2 Company Description and Business Overview 12.1.3 Overactive Bladder Treatment Drug Introduction 12.1.4 Astellas Pharma, Inc. (Japan) Revenue in Overactive Bladder Treatment Drug Business (2013-2018) 12.1.5 Astellas Pharma, Inc. (Japan) Recent Development 12.2 Pfizer, Inc. (U.S.) 12.2.1 Pfizer, Inc. (U.S.) Company Details 12.2.2 Company Description and Business Overview 12.2.3 Overactive Bladder Treatment Drug Introduction 12.2.4 Pfizer, Inc. (U.S.) Revenue in Overactive Bladder Treatment Drug Business (2013-2018) 12.2.5 Pfizer, Inc. (U.S.) Recent Development 12.3 Teva Pharmaceutical Industries Limited (Israel) 12.3.1 Teva Pharmaceutical Industries Limited (Israel) Company Details 12.3.2 Company Description and Business Overview 12.3.3 Overactive Bladder Treatment Drug Introduction 12.3.4 Teva Pharmaceutical Industries Limited (Israel) Revenue in Overactive Bladder Treatment Drug Business (2013-2018) 12.3.5 Teva Pharmaceutical Industries Limited (Israel) Recent Development 12.4 Allergan, Plc (Ireland) 12.4.1 Allergan, Plc (Ireland) Company Details 12.4.2 Company Description and Business Overview 12.4.3 Overactive Bladder Treatment Drug Introduction 12.4.4 Allergan, Plc (Ireland) Revenue in Overactive Bladder Treatment Drug Business (2013-2018) 12.4.5 Allergan, Plc (Ireland) Recent Development 12.5 Medtronic plc (Ireland) 12.5.1 Medtronic plc (Ireland) Company Details 12.5.2 Company Description and Business Overview 12.5.3 Overactive Bladder Treatment Drug Introduction 12.5.4 Medtronic plc (Ireland) Revenue in Overactive Bladder Treatment Drug Business (2013-2018) 12.5.5 Medtronic plc (Ireland) Recent Development 12.6 Mylan N.V. (U.S.) 12.6.1 Mylan N.V. (U.S.) Company Details 12.6.2 Company Description and Business Overview 12.6.3 Overactive Bladder Treatment Drug Introduction 12.6.4 Mylan N.V. (U.S.) Revenue in Overactive Bladder Treatment Drug Business (2013-2018) 12.6.5 Mylan N.V. (U.S.) Recent Development 12.7 Endo International plc (Ireland) 12.7.1 Endo International plc (Ireland) Company Details 12.7.2 Company Description and Business Overview 12.7.3 Overactive Bladder Treatment Drug Introduction 12.7.4 Endo International plc (Ireland) Revenue in Overactive Bladder Treatment Drug Business (2013-2018) 12.7.5 Endo International plc (Ireland) Recent Development 12.8 Hisamitsu Pharmaceutical Co., Inc. (Japan) 12.8.1 Hisamitsu Pharmaceutical Co., Inc. (Japan) Company Details 12.8.2 Company Description and Business Overview 12.8.3 Overactive Bladder Treatment Drug Introduction 12.8.4 Hisamitsu Pharmaceutical Co., Inc. (Japan) Revenue in Overactive Bladder Treatment Drug Business (2013-2018) 12.8.5 Hisamitsu Pharmaceutical Co., Inc. (Japan) Recent Development 12.9 Sanofi (France) 12.9.1 Sanofi (France) Company Details 12.9.2 Company Description and Business Overview 12.9.3 Overactive Bladder Treatment Drug Introduction 12.9.4 Sanofi (France) Revenue in Overactive Bladder Treatment Drug Business (2013-2018) 12.9.5 Sanofi (France) Recent Development 12.10 Apotex, Inc. (Canada) 12.10.1 Apotex, Inc. (Canada) Company Details 12.10.2 Company Description and Business Overview 12.10.3 Overactive Bladder Treatment Drug Introduction 12.10.4 Apotex, Inc. (Canada) Revenue in Overactive Bladder Treatment Drug Business (2013-2018) 12.10.5 Apotex, Inc. (Canada) Recent Development 12.11 Cogentix Medical, Inc. (U.S.) 12.12 Aurobindo Pharma Limited (India) 13 Market Forecast 2018-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2018-2025) 13.10 Market Size Forecast by Application (2018-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details
List of Tables and Figures Table Overactive Bladder Treatment Drug Key Market Segments Table Key Players Overactive Bladder Treatment Drug Covered Table Global Overactive Bladder Treatment Drug Market Size Growth Rate by Type 2013-2025 (Million US$) Figure Global Overactive Bladder Treatment Drug Market Size Market Share by Type 2013-2025 Figure Anticholinergics Figures Table Key Players of Anticholinergics Figure Solifenacin Figures Table Key Players of Solifenacin Figure Oxybutynin Figures Table Key Players of Oxybutynin Figure Darifenacin Figures Table Key Players of Darifenacin Figure Fesoterodine Figures Table Key Players of Fesoterodine Figure Tolterodine Figures Table Key Players of Tolterodine Figure Trospium Figures Table Key Players of Trospium Figure Others Figures Table Key Players of Others Table Global Overactive Bladder Treatment Drug Market Size Growth by Application 2013-2025 (Million US$) Figure Idiopathic Bladder Overactivity Case Studies Figure Neurogenic Bladder Overactivity Case Studies Figure Overactive Bladder Treatment Drug Report Years Considered Table Global Overactive Bladder Treatment Drug Market Size 2013-2025 (Million US$) Figure Global Overactive Bladder Treatment Drug Market Size and Growth Rate 2013-2025 (Million US$) Table Global Overactive Bladder Treatment Drug Market Size by Regions 2013-2025 (Million US$) Table Global Overactive Bladder Treatment Drug Market Size by Regions 2013-2018 (Million US$) Table Global Overactive Bladder Treatment Drug Market Share by Regions 2013-2018 Figure Global Overactive Bladder Treatment Drug Market Share by Regions 2013-2018 Figure Global Overactive Bladder Treatment Drug Market Share by Regions 2018 Table Market Top Trends Table Global Overactive Bladder Treatment Drug Revenue by Manufacturers (2013-2018) (Million US$) Table Global Overactive Bladder Treatment Drug Market Share by Manufacturers (2013-2018) Figure Global Overactive Bladder Treatment Drug Market Share by Manufacturers in 2018 Table Global Overactive Bladder Treatment Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Overactive Bladder Treatment Drug Product/Solution/Service Table Date of Enter into Overactive Bladder Treatment Drug Market Table Mergers & Acquisitions, Expansion Plans Table Global Overactive Bladder Treatment Drug Market Size by Type (2013-2018) (Million US$) Table Global Overactive Bladder Treatment Drug Market Size Share by Type (2013-2018) Figure Global Overactive Bladder Treatment Drug Market Size Market Share by Type (2013-2018) Table Global Overactive Bladder Treatment Drug Market Size by Application (2013-2018) (Million US$) Table Global Overactive Bladder Treatment Drug Market Size Share by Application (2013-2018) Figure Global Overactive Bladder Treatment Drug Market Size Market Share by Application (2013-2018) Figure Global Overactive Bladder Treatment Drug Revenue Market Share by Application in 2017 Figure United States Overactive Bladder Treatment Drug Market Size 2013-2018 (Million US$) Table United States Key Players Overactive Bladder Treatment Drug Revenue (2017-2018) (Million US$) Table United States Key Players Overactive Bladder Treatment Drug Market Share (2017-2018) Table United States Overactive Bladder Treatment Drug Market Size by Type (2013-2018) (Million US$) Table United States Overactive Bladder Treatment Drug Market Share by Type (2013-2018) Table United States Overactive Bladder Treatment Drug Market Size by Application (2013-2018) (Million US$) Table United States Overactive Bladder Treatment Drug Market Share by Application (2013-2018) Figure Europe Overactive Bladder Treatment Drug Market Size 2013-2018 (Million US$) Table Europe Key Players Overactive Bladder Treatment Drug Revenue (2017-2018) (Million US$) Table Europe Key Players Overactive Bladder Treatment Drug Market Share (2017-2018) Table Europe Overactive Bladder Treatment Drug Market Size by Type (2013-2018) (Million US$) Table Europe Overactive Bladder Treatment Drug Market Share by Type (2013-2018) Table Europe Overactive Bladder Treatment Drug Market Size by Application (2013-2018) (Million US$) Table Europe Overactive Bladder Treatment Drug Market Share by Application (2013-2018) Figure China Overactive Bladder Treatment Drug Market Size 2013-2018 (Million US$) Table China Key Players Overactive Bladder Treatment Drug Revenue (2017-2018) (Million US$) Table China Key Players Overactive Bladder Treatment Drug Market Share (2017-2018) Table China Overactive Bladder Treatment Drug Market Size by Type (2013-2018) (Million US$) Table China Overactive Bladder Treatment Drug Market Share by Type (2013-2018) Table China Overactive Bladder Treatment Drug Market Size by Application (2013-2018) (Million US$) Table China Overactive Bladder Treatment Drug Market Share by Application (2013-2018) Figure Japan Overactive Bladder Treatment Drug Market Size 2013-2018 (Million US$) Table Japan Key Players Overactive Bladder Treatment Drug Revenue (2017-2018) (Million US$) Table Japan Key Players Overactive Bladder Treatment Drug Market Share (2017-2018) Table Japan Overactive Bladder Treatment Drug Market Size by Type (2013-2018) (Million US$) Table Japan Overactive Bladder Treatment Drug Market Share by Type (2013-2018) Table Japan Overactive Bladder Treatment Drug Market Size by Application (2013-2018) (Million US$) Table Japan Overactive Bladder Treatment Drug Market Share by Application (2013-2018) Figure Southeast Asia Overactive Bladder Treatment Drug Market Size 2013-2018 (Million US$) Table Southeast Asia Key Players Overactive Bladder Treatment Drug Revenue (2017-2018) (Million US$) Table Southeast Asia Key Players Overactive Bladder Treatment Drug Market Share (2017-2018) Table Southeast Asia Overactive Bladder Treatment Drug Market Size by Type (2013-2018) (Million US$) Table Southeast Asia Overactive Bladder Treatment Drug Market Share by Type (2013-2018) Table Southeast Asia Overactive Bladder Treatment Drug Market Size by Application (2013-2018) (Million US$) Table Southeast Asia Overactive Bladder Treatment Drug Market Share by Application (2013-2018) Figure India Overactive Bladder Treatment Drug Market Size 2013-2018 (Million US$) Table India Key Players Overactive Bladder Treatment Drug Revenue (2017-2018) (Million US$) Table India Key Players Overactive Bladder Treatment Drug Market Share (2017-2018) Table India Overactive Bladder Treatment Drug Market Size by Type (2013-2018) (Million US$) Table India Overactive Bladder Treatment Drug Market Share by Type (2013-2018) Table India Overactive Bladder Treatment Drug Market Size by Application (2013-2018) (Million US$) Table India Overactive Bladder Treatment Drug Market Share by Application (2013-2018) Figure Central & South America Overactive Bladder Treatment Drug Market Size 2013-2018 (Million US$) Table Central & South America Key Players Overactive Bladder Treatment Drug Revenue (2017-2018) (Million US$) Table Central & South America Key Players Overactive Bladder Treatment Drug Market Share (2017-2018) Table Central & South America Overactive Bladder Treatment Drug Market Size by Type (2013-2018) (Million US$) Table Central & South America Overactive Bladder Treatment Drug Market Share by Type (2013-2018) Table Central & South America Overactive Bladder Treatment Drug Market Size by Application (2013-2018) (Million US$) Table Central & South America Overactive Bladder Treatment Drug Market Share by Application (2013-2018) Table Astellas Pharma, Inc. (Japan) Company Details Table Astellas Pharma, Inc. (Japan) Revenue in Overactive Bladder Treatment Drug Business (2013-2018) (Million US$) Figure Astellas Pharma, Inc. (Japan) Revenue Growth Rate in Overactive Bladder Treatment Drug Business (2013-2018) Table Astellas Pharma, Inc. (Japan) Recent Development Table Pfizer, Inc. (U.S.) Company Details Table Pfizer, Inc. (U.S.) Revenue in Overactive Bladder Treatment Drug Business (2013-2018)(Million US$) Figure Pfizer, Inc. (U.S.) Revenue Growth Rate in Overactive Bladder Treatment Drug Business (2013-2018) Table Pfizer, Inc. (U.S.) Recent Development Table Teva Pharmaceutical Industries Limited (Israel) Company Details Table Teva Pharmaceutical Industries Limited (Israel) Revenue in Overactive Bladder Treatment Drug Business (2013-2018)(Million US$) Figure Teva Pharmaceutical Industries Limited (Israel) Revenue Growth Rate in Overactive Bladder Treatment Drug Business (2013-2018) Table Teva Pharmaceutical Industries Limited (Israel) Recent Development Table Allergan, Plc (Ireland) Company Details Table Allergan, Plc (Ireland) Revenue in Overactive Bladder Treatment Drug Business (2013-2018)(Million US$) Figure Allergan, Plc (Ireland) Revenue Growth Rate in Overactive Bladder Treatment Drug Business (2013-2018) Table Allergan, Plc (Ireland) Recent Development Table Medtronic plc (Ireland) Company Details Table Medtronic plc (Ireland) Revenue in Overactive Bladder Treatment Drug Business (2013-2018)(Million US$) Figure Medtronic plc (Ireland) Revenue Growth Rate in Overactive Bladder Treatment Drug Business (2013-2018) Table Medtronic plc (Ireland) Recent Development Table Mylan N.V. (U.S.) Company Details Table Mylan N.V. (U.S.) Revenue in Overactive Bladder Treatment Drug Business (2013-2018)(Million US$) Figure Mylan N.V. (U.S.) Revenue Growth Rate in Overactive Bladder Treatment Drug Business (2013-2018) Table Mylan N.V. (U.S.) Recent Development Table Endo International plc (Ireland) Company Details Table Endo International plc (Ireland) Revenue in Overactive Bladder Treatment Drug Business (2013-2018)(Million US$) Figure Endo International plc (Ireland) Revenue Growth Rate in Overactive Bladder Treatment Drug Business (2013-2018) Table Endo International plc (Ireland) Recent Development Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Company Details Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Revenue in Overactive Bladder Treatment Drug Business (2013-2018)(Million US$) Figure Hisamitsu Pharmaceutical Co., Inc. (Japan) Revenue Growth Rate in Overactive Bladder Treatment Drug Business (2013-2018) Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Recent Development Table Sanofi (France) Company Details Table Sanofi (France) Revenue in Overactive Bladder Treatment Drug Business (2013-2018)(Million US$) Figure Sanofi (France) Revenue Growth Rate in Overactive Bladder Treatment Drug Business (2013-2018) Table Sanofi (France) Recent Development Table Apotex, Inc. (Canada) Company Details Table Apotex, Inc. (Canada) Revenue in Overactive Bladder Treatment Drug Business (2013-2018)(Million US$) Figure Apotex, Inc. (Canada) Revenue Growth Rate in Overactive Bladder Treatment Drug Business (2013-2018) Table Apotex, Inc. (Canada) Recent Development Table Cogentix Medical, Inc. (U.S.) Company Details Table Aurobindo Pharma Limited (India) Company Details Table Global Overactive Bladder Treatment Drug Market Size by Regions (Million US$) 2018-2025 Figure Global Overactive Bladder Treatment Drug Market Size Share by Regions (2018-2025) Figure Global Overactive Bladder Treatment Drug Market Size Share by Regions in 2025 Figure United States Overactive Bladder Treatment Drug Market Size Forecast (2018-2025)(Million USD) Figure Europe Overactive Bladder Treatment Drug Market Size Forecast (2018-2025)(Million USD) Figure China Overactive Bladder Treatment Drug Market Size Forecast (2018-2025)(Million USD) Figure Japan Overactive Bladder Treatment Drug Market Size Forecast (2018-2025)(Million USD) Figure Southeast Asia Overactive Bladder Treatment Drug Market Size Forecast (2018-2025)(Million USD) Figure India Overactive Bladder Treatment Drug Market Size Forecast (2018-2025)(Million USD) Figure Central & South America Overactive Bladder Treatment Drug Market Size Forecast (2018-2025)(Million USD) Table Global Overactive Bladder Treatment Drug Market Size by Product (2018-2025) (Million US$) Figure Global Overactive Bladder Treatment Drug Market Size by Product (2018-2025) Figure Global Overactive Bladder Treatment Drug Market Size by Product in 2025 Table Global Overactive Bladder Treatment Drug Market Size by Application (2018-2025) (Million US$) Figure Global Overactive Bladder Treatment Drug Market Size by Application (2018-2025) Figure Global Overactive Bladder Treatment Drug Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.